We found FOSL1 levels were positively correlated with the glioma grades in a total of 75 glioma patients (Fig. 7) and correlated to the established GSC markers ALDH1 and TRPM7 (Fig. 8), suggesting FOSL1 is a diagnostic marker and potential therapeutic target for glioma patients. Here, ALDH1A1 is linked to central nervous system cancer.